WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
U.S. Targeting of Chinese Scientists Fuels a Brain Drain(7/18/2019 )  (Premium)
Trade War and China's Changing Trade Mark Law(7/16/2019 )  (Premium)
The Market
SMEI President Reviews Pharma Industry Performance with Lowered Growth Forecast for 2019(7/16/2019 )  (Premium)
Industry News
Alphamab Oncology Files IPO at HKEX(7/18/2019 )  (Premium)
GenScript's Biologics R&D and Production Center Becomes Operation(7/18/2019 )  (free)
SMEI Releases Rankings of Top 100 Chinese Retail Pharmacy Chains in 2018(7/18/2019 )  (Premium)
60% of 135 Listed Biopharma Companies Issued Positive H1 Performance Guidance(7/17/2019 )  (Premium)
China Daily: Latest Healthy China Guideline Targets Chronic Illnesses(7/17/2019 )  (Premium)
X4 and Abbisko Enter Oncology Development Partnership for Mavorixafor in Greater China(7/17/2019 )  (Premium)
Cipla Re-enters Chinese Market in JV with Jiangsu Acebright Pharma(7/16/2019 )  (Premium)
SMEI Releases Ranking of Top 100 Chinese Biopharma Companies in 2018(7/16/2019 )  (Premium)
Chinese Biopharma Startups Raised $1,645M and Launched Seven IPOs in H1(7/16/2019 )  (Premium)
Luye Pharma's Transdermal Patch Receives German Medical Regulatory Approval(7/16/2019 )  (Premium)
CDE Issues Notice on Reference of Exemption Guidelines for Human BE Studies(7/15/2019 )  (Premium)
SinoMab Files IPO in Hong Kong, Making It the First Homegrown Biotech To Do So(7/15/2019 )  (Premium)
Regulatory News
State Council Issues Policy to Establish Inspection Forces for Drug Safety(7/18/2019 )  (free)
CDE Unleashes Mid-Year Report on Clinical Trial Registration with BE Tests Accounting for 19%(7/18/2019 )  (Premium)
NMPA Issues New Document on Linked Evaluation and Approval of APIs, Excipients and Packaging Materials(7/17/2019 )  (Premium)
General Health
Snapshot of BMI System Financial Performance in H1/2019(7/18/2019 )  (Premium)
State Council Issues the Action Plan for Healthy China Initiative(7/15/2019 )  (Premium)
Central Government Urges to Enhanced Basic Medical Care for Impoverished Population(7/15/2019 )  (free)
People in the News
Swiss Agrees to Extradite Chinese Scientist to US for Corporate Espionage(7/16/2019 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links